Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA). "This trifecta of ...
Stock-based compensation decreased by approximately $340 thousand in the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to stock options ...
The logo, featuring “Tulare” in colorful capital letters embedded with the silhouettes of some of the things the city is best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback